. A phase 2, open-label study of anti-inflammatory NE3107 in patients with dementias. Medicine (Baltimore). 2024 Jul 26;103(30):e39027. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

Therapeutics

  1. Bezisterim